Physical Activity Promoting Active Aging
Physical Activity Promoting Active Aging: An Exploration of Intrinsic Mechanisms and Practical Pathways
This project aims to explore the effects and underlying mechanisms of physical activity in promoting active aging among older adults. The researchers conducted two rounds of progressive randomized controlled intervention trials to verify the effects and mechanisms of a multimodal physical activity intervention on active aging from two dimensions: intervention structure and participation mode.
In Study 1, with a 12-week intervention period, participants were randomly assigned to three groups: a Tai Chi exercise group, a multimodal exercise group, and a daily activity control group. By comparing between-group differences, the study evaluated the effects of different exercise modalities on physical function and subjective active aging.
In Study 2, also with a 12-week intervention period, participants were randomly assigned to two multimodal exercise groups differing in participation mode: an in-person group-based format versus an online individual format. This study examined the moderating effects of different participation modes on both objective and subjective active aging outcomes, while keeping the multimodal physical activity intervention content identical.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Zhejiang
-
Hangzhou, Zhejiang, Porcelana, 310058
- Department of Sports Science, College of Education, Zhejiang University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Aged 60 years or above;
Capable of engaging in regular physical activities and comprehending basic testing procedures and instructions.
Exclusion Criteria:
- Severe cardiac, pulmonary, or musculoskeletal disorders;
History of neurological or psychiatric conditions that may impair cognitive function (e.g., stroke, Parkinson's disease, Alzheimer's disease, major depressive disorder, etc.);
Missing three or more scheduled intervention sessions during the study period, or requesting discontinuation of participation.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Grupo de control
|
|
|
Experimental: Grupo de ejercicios multicomponente
|
Tai Chi, Baduanjin, strength, balance, and flexibility exercises
|
|
Experimental: Mind-body exercise group
|
Tai Chi, Yoga, and Baduanjin
|
|
Experimental: Online-based multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered via live online streaming and video watching)
|
|
Experimental: In-person multicomponent exercise group
|
Tai Chi, Baduanjin, and strength, balance, and flexibility exercises (delivered in an in-person group format)
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Active aging
Periodo de tiempo: week0, week6, week12
|
It was measured using the Active Aging Questionnaire.
|
week0, week6, week12
|
|
General self-efficacy
Periodo de tiempo: week0, week6, week12
|
It was measured using the General Self-Efficacy Scale.
|
week0, week6, week12
|
|
Cognitive function
Periodo de tiempo: week0, week6, week12
|
Cognitive function was measured using the cognitive subscale of the LEIPAD questionnaire
|
week0, week6, week12
|
|
Cognitive function assessed by the Montreal Cognitive Assessment (MOCA)
Periodo de tiempo: week0, week6, week12
|
Cognitive function was measured using the Montreal Cognitive Assessment (MOCA).
|
week0, week6, week12
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Height
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
|
|
Weight
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
|
|
Body fat percentage
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
|
|
Vital capacity test
Periodo de tiempo: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
2-minute high-knee marching in place
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
|
|
Handgrip strength
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
|
|
Sit and reach test
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
|
|
30-second chair stand test
Periodo de tiempo: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
One-legged stance with eyes closed tesr
Periodo de tiempo: week0, week6, week12
|
Physiological parameter
|
week0, week6, week12
|
|
Choice reaction time
Periodo de tiempo: week0, week6, week12
|
week0, week6, week12
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- ZJU-SSEC/2025/No.6
- 23NDJC001Z (Otro número de subvención/financiamiento: Key Program of Philosophy and Social Sciences Planning of Zhejiang Province)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .